| Literature DB >> 33968103 |
Wei Wu1, Wenhua Chen1, Shiyu Liu1, Jianjun Wu1, Yeting Zhu1, Luping Qin1, Bo Zhu1.
Abstract
Plants benefit extensively from endophytic bacteria, which live in host plant tissues exerting no harmful effects. Bacterial endophytes promote the growth of host plants and enhance their resistance toward various pathogens and environmental stresses. They can also regulate the synthesis of secondary metabolites with significant medicinal properties and produce various biological effects. This review summarizes recent studies on the relationships between bacterial endophytes and medicinal plants. Endophytic bacteria have numerous applications in agriculture, medicine, and other industries: improving plant growth, promoting resistance toward both biotic and abiotic stresses, and producing metabolites with medicinal potential. Their distribution and population structure are affected by their host plant's genetic characteristics and health and by the ecology of the surrounding environment. Understanding bacterial endophytes can help us use them more effectively and apply them to medicinal plants to improve yield and quality.Entities:
Keywords: bacterial community; endophytic bacteria; medicinal plants; plant growth-promoting bacteria; plant-microbe relationships; secondary metabolites
Year: 2021 PMID: 33968103 PMCID: PMC8100581 DOI: 10.3389/fpls.2021.646146
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Factors affecting the community structure of endophytic bacteria in medicinal plants.
| Habitat | Representative host plant | Isolated part(s) | Factor(s) | Factor(s) explanatory comments | References |
| Mountains in subtropics | Root | Environment: altitude | Different dominant endophytic bacteria | ||
| Mountains in subtropics | Leaf, stem, and root | Tissue | The OTUs number of endophytic bacteria from high to low in different tissues were leaf > stem > root | ||
| Karst landform | Root | Environment: soil type | The highest endophyte numbers were observed in low calcium soil | ||
| Grassland habitat in savanna | Root and leaf | Tissue | The OTUs number of endophytic bacteria from high to low in different tissues were root > leaf | ||
| Plantation | Leaf | Health status of plants | Lower relative abundance in healthy plants than in susceptible plants | ||
| Temperate maritime climate islands | Leaf, stem and root | Tissue age | The species richness of endophytic bacteria increased with tissue age | ||
| Temperate forest | Leaf | Season | The order of the endophytes richness in the samples was spring > summer > early winter | ||
| Subtropical region | Branch | Season | Spring samples harbor higher bacterial OTUs, α-diversity, and bacterial community complexity than autumn samples | ||
| Mediterranean region | Root | Environment: moisture | Endophyte colonization was positively correlated with humidity | ||
| Subtropical botanical gardens | Rhizome | Taxonomy of plants | Different dominant endophytic bacteria |
FIGURE 1Taxonomy of the 86 species of medicinal plants included in the survey and reference analysis (x-axis: number of species in the family; y-axis: type of family).
FIGURE 2Geographical distribution of medicinal plants and related endophytic bacteria, considered in the survey.
Beneficial relationships between endophytic bacteria and host plants.
| Role of beneficial bacteria | Host plant | Endophytic bacteria | Effect(s) | References |
| Plant growth promotion | Enhanced seedling biomass | |||
| Increased adventitious root formation and the rooting capacity of cuttings | ||||
| Increased root length, weights, and root area | ||||
| Increased root length, shoot length, and dry weight | ||||
| Increased root length, shoot length, and root number | ||||
| Increased shoot and root length and fresh and dry weight | ||||
| Increased shoot length, fresh shoot and root weight, and leaf area | ||||
| Enhanced plant resistance to phytopathogens | Protection of host plants from phytopathogen infection | |||
| Induced host disease resistance | ||||
| Suppressed pathogen mycelial growth | ||||
| Induction of plant defense mechanisms | ||||
| Produced antibiotics and induced systemic resistance | ||||
| Depressed the growth of the pathogens | ||||
| Improved plant abiotic stress tolerance | Improved tolerance to high NaCl concentration | |||
| Increased germination percentage and root weight under saline conditions | ||||
| Degraded phenanthrene | ||||
| Relieved plant heavy metal stress | ||||
| Reduced arsenate to arsenite | ||||
| Removed airborne benzene | ||||
| Promotion of plant metabolites accumulation | Increased production of sesquiterpenoids | |||
| Essential oil accumulation | ||||
| Induced production of ginsenoside | ||||
| Promoted ligustrazine accumulation | ||||
| Increased artemisinin content | ||||
| Increased ginsenoside Rg3 |
Secondary metabolites originated from endophytic bacteria in medicinal plants and their bio-properties.
| Class | Compounds | Endophytic bacteria | Host plant | Bio-properties | References |
| Alkaloids | 6-Prenylindole | Antifungal activity | |||
| 1-Acetyl-β-carboline | Antibacterial activity | ||||
| Indole-3-carbaldehyde | |||||
| 3-(Hydroxyacetyl)-Indole | |||||
| Brevianamide F | |||||
| 3-Acetonylidene-7-Prenylindolin-2-one | Antifungal activity | ||||
| 7-Isoprenylindole-3-carboxylic acid | |||||
| Vindoline | Treating Hodgkin’s disease and acute leukemia | ||||
| Camptothecin | Anticancer activity | ||||
| 2,3-dihydro-2,2-dimethyl-4(1H)-quinazolinone | Anticancer activity | ||||
| Indole-3-acetic acid | Promoting plant root development and carbohydrates provide | ||||
| Berberine | Anti-inflammatory, anti-tumor, and lowering blood sugar activities | ||||
| Sesquiterpenes | Xiamycin | Anti-HIV activity | |||
| Trichodones A-C | |||||
| Guignarderemophilanes A-E | Anti-inflammatory activity | ||||
| Polyketones | Grignard dene A | Anti-inflammatory activity | |||
| Grignard lactone A | |||||
| Naphthomycins A, D, E, L, K, O-Q | Antimicrobial activity | ||||
| Lactones | Cedarmycin A | Antifungal and antibacterial activities | |||
| Cedarmycin B | |||||
| Daunorubicin | Anticancer activity | ||||
| Hookerolide | Antimicrobial activities | ||||
| 24-demethyl-bafifilomycin A2, Z | |||||
| Organic acids | Trans cinnamic acid | Antimicrobial activity | |||
| Benzoic acid | |||||
| phthalic acid | Antifungal and antibacterial activities | ||||
| Cyclopeptides | cyclo(L-Tyr-L Pro-L-Phe-trans-4-hydroxy-L-Pro) | Antimicrobial activity | |||
| cyclo(L-Phe-trans-4-hydroxy-L-Pro) | |||||
| cyclo(L-Val-L-Tyr) | |||||
| Halobacillin | Anti-HIV activity | ||||
| Flavonoids | 7-Methoxy-3,3′,4′,6-tetrahydroxyflavone | Anticancer activity | |||
| 2′,7-Dihydroxy-4′,5′-Dimethoxyisoflavone | |||||
| Fisetin | |||||
| Saponins | Ginsenoside Rg3 | Anticancer activity | |||
| Ginsenoside Rh2 | Anticancer activity | ||||
| Others | Ligustrazine | Treating ischemic vascular related diseases | |||
| Linfuranone A | - | ||||
| 5,7-Dimethoxy-4-phenylcoumarin | - | ||||
| bis (2-ethylhexyl) phthalate | Antimicrobial activity | ||||
| 1,3- dimethyl-, p-xylene | |||||
| dibutyl phthalate | |||||
| Tetracosane | |||||
| 1- –Heptacosanol | Antimicrobial activity |